Last reviewed · How we verify
NCT05891431
Engagement and Acceptability of the Untire mHealth App
NA trial testing Untire mobile app in Cancer-related Problem/Condition in 34 participants. Participants enrolled and being followed up; not accepting new ones.
16 September 2024
Quick facts
| Lead sponsor | University of Bath |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 15 December 2023 |
| Primary completion | 16 September 2024 |
| Estimated completion | 1 October 2025 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Untire mobile app
Conditions studied
- Cancer-related Problem/Condition — all drugs for Cancer-related Problem/Condition →
- Cancer-related Fatigue — all drugs for Cancer-related Fatigue →
Sponsor
University of Bath
Who can join
18 and older, any sex, with Cancer-related Problem/Condition or Cancer-related Fatigue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study will be to assess the engagement and acceptability of the Untire mHealth intervention for adults with cancer related fatigue. Acceptability will be assessed after 2, 4, 6 and 12 weeks of app use. Participants (both those competed the study and those who stopped using the app) will be asked about their engagement with the app. A secondary aim of this study will be to provide preliminary efficacy outcomes of the Untire intervention in reducing fatigue and QoL in adults experiencing cancer related fatigue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05891431
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer-related Problem/Condition
Currently open trials in the same condition.
- NCT06754722 — Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors · NA · recruiting
- NCT06839794 — Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients · NA · recruiting
- NCT06809101 — Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Bal · recruiting
- NCT06717178 — Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China · recruiting
- NCT05226078 — The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients · NA · active not recruiting
Other University of Bath trials
Trials by the same sponsor.
- NCT07360249 — Glucose-fructose Ratio Pilot · NA · recruiting
- NCT06967077 — Exploring the Feasibility and Acceptability of Virtual Reality Exercise for Pain Management, Fear of Movement, Mobility, · NA · not yet recruiting
- NCT07472244 — Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation? · NA · recruiting
- NCT07099911 — Neuromuscular Electrical Stimulation and Glucose Control in Spinal Cord Injury · NA · recruiting
- NCT07027553 — Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05891431 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Bath
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05891431.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing